Authors:
RAYNAUD FI
BOXALL FE
WONG T
GODDARD K
NUTLEY B
BARNARD CFJ
MURRER B
ABRAMS M
KELLAND LR
Citation: Fi. Raynaud et al., BIOTRANSFORMATION OF AMD473, A NOVEL PLATINUM ANALOG IN PLASMA, CELL-CULTURE AND TISSUE, Annals of oncology, 9, 1998, pp. 190-190
Citation: Lr. Kelland et al., INHIBITION OF HUMAN TELOMERASE AND GROWTH OF HUMAN OVARIAN-CARCINOMA CELL-LINES BY 2,6-DISUBSTITUTED AMIDO-ANTHRACENE-9,10 DIONES, Annals of oncology, 9, 1998, pp. 540-540
Authors:
HENDERSON ND
LACY SM
OHARE CC
HARTLEY JA
MCCLEAN S
WAKELIN LPG
KELLAND LR
ROBINS DJ
Citation: Nd. Henderson et al., SYNTHESIS OF NEW BIFUNCTIONAL COMPOUNDS WHICH SELECTIVELY ALKYLATE GUANINES IN DNA, Anti-cancer drug design (Print), 13(7), 1998, pp. 749-768
Authors:
HOLFORD J
RAYNAUD F
MURRER BA
GRIMALDI K
HARTLEY JA
ABRAMS M
KELLAND LR
Citation: J. Holford et al., CHEMICAL, BIOCHEMICAL AND PHARMACOLOGICAL ACTIVITY OF THE NOVEL STERICALLY HINDERED PLATINUM COORDINATION COMPLEX, CIS-[AMMINEDICHLORO(2-METHYLPYRIDINE)] PLATINUM(II) (AMD473), Anti-cancer drug design, 13(1), 1998, pp. 1-18
Authors:
HODGKINSON TJ
KELLAND LR
SHIPMAN M
VILE J
Citation: Tj. Hodgkinson et al., SYNTHESIS AND REACTIVITY OF SOME CHIRAL, NONRACEMIC 1-AZABICYCLO[4.1.0]HEPTANES RELATED TO THE AZINOMYCINS, Tetrahedron, 54(22), 1998, pp. 6029-6034
Authors:
PERRY PJ
RESZKA AP
WOOD AA
READ MA
GOWAN SM
DOSANJH HS
TRENT JO
JENKINS TC
KELLAND LR
NEIDLE S
Citation: Pj. Perry et al., HUMAN TELOMERASE INHIBITION BY REGIOISOMERIC DISUBSTITUTED AMIDOANTHRACENE-9,10-DIONES, Journal of medicinal chemistry, 41(24), 1998, pp. 4873-4884
Authors:
PERRY PJ
GOWAN SM
RESZKA AP
POLUCCI P
JENKINS TC
KELLAND LR
NEIDLE S
Citation: Pj. Perry et al., 1,4-DISUBSTITUTED AND 2,6-DISUBSTITUTED AMIDOANTHRACENE-9,10-DIONE DERIVATIVES AS INHIBITORS OF HUMAN TELOMERASE, Journal of medicinal chemistry, 41(17), 1998, pp. 3253-3260
Authors:
PESTELL KE
MEDLOW CJ
TITLEY JC
KELLAND LR
WALTON MI
Citation: Ke. Pestell et al., CHARACTERIZATION OF THE P53 STATUS, BCL-2 EXPRESSION AND RADIATION AND PLATINUM DRUG-SENSITIVITY OF A PANEL OF HUMAN OVARIAN-CANCER CELL-LINES, International journal of cancer, 77(6), 1998, pp. 913-918
Citation: J. Holford et al., RAS MUTATION AND PLATINUM RESISTANCE IN HUMAN OVARIAN CARCINOMAS IN-VITRO, International journal of cancer, 77(1), 1998, pp. 94-100
Citation: Sy. Sharp et al., LACK OF A ROLE FOR MRP1 IN PLATINUM DRUG-RESISTANCE IN HUMAN OVARIAN-CANCER CELL-LINES, British Journal of Cancer, 78(2), 1998, pp. 175-180
Authors:
PESTELL KE
MEDLOW CJ
JONES M
VALENTI M
BRUNTON L
KELLAND LR
WALTON MI
Citation: Ke. Pestell et al., ROLE OF P53 IN HUMAN OVARIAN-CANCER TUMOR XENOGRAFTS CURABLE WITH CISPLATIN, British Journal of Cancer, 78, 1998, pp. 14-14
Citation: Lr. Kelland et al., 2.6-DISUBSTITUTED AMIDO-ANTHRACENE-9,10 DIONES - SMALL-MOLECULE INHIBITORS OF HUMAN TELOMERASE, British Journal of Cancer, 78, 1998, pp. 64-64
Authors:
WALTON MI
KOSHY P
MEDLOW CJ
SHARP S
KELLAND LR
SHARP S
TITLEY J
Citation: Mi. Walton et al., THE ROLE OF FUNCTIONAL P53 IN CISPLATIN CHEMOSENSITIVITY IN A PANEL OF HUMAN OVARIAN-CANCER CELL-LINES, British Journal of Cancer, 78, 1998, pp. 69-69
Authors:
HOLFORD J
SHARP SY
MURRER BA
ABRAMS M
KELLAND LR
Citation: J. Holford et al., IN-VITRO CIRCUMVENTION OF CISPLATIN RESISTANCE BY THE NOVEL STERICALLY HINDERED PLATINUM COMPLEX AMD473, British Journal of Cancer, 77(3), 1998, pp. 366-373
Authors:
RAYNAUD FI
BOXALL FE
GODDARD PM
VALENTI M
JONES M
MURRER BA
ABRAMS M
KELLAND LR
Citation: Fi. Raynaud et al., CIS-AMINEDICHLORO(2-METHYLPYRIDINE)PLATINUM(II) (AMD473), A NOVEL STERICALLY HINDERED PLATINUM COMPLEX - IN-VIVO ACTIVITY, TOXICOLOGY, AND PHARMACOKINETICS IN MICE, Clinical cancer research, 3(11), 1997, pp. 2063-2074
Authors:
NEIDLE S
KELLAND LR
TRENT JO
SIMPSON IJ
BOYKIN DW
KUMAR A
WILSON WD
Citation: S. Neidle et al., CYTOTOXICITY OF BIS(PHENYLAMIDINIUM)FURAN ALKYL DERIVATIVES IN HUMAN TUMOR-CELL LINES - RELATION TO DNA MINOR-GROOVE BINDING, Bioorganic & medicinal chemistry letters, 7(11), 1997, pp. 1403-1408
Authors:
MCKEAGE MJ
RAYNAUD F
WARD J
BERRY C
ODELL D
KELLAND LR
MURRER B
SANTABARABARA P
HARRAP KR
JUDSON IR
Citation: Mj. Mckeage et al., PHASE-I AND PHARMACOKINETIC STUDY OF AN ORAL PLATINUM COMPLEX GIVEN DAILY FOR 5 DAYS IN PATIENTS WITH CANCER, Journal of clinical oncology, 15(7), 1997, pp. 2691-2700
Authors:
ANTONINI I
POLUCCI P
JENKINS TC
KELLAND LR
MENTA E
PESCALLI N
STEFANSKA B
MAZERSKI J
MARTELLI S
Citation: I. Antonini et al., AMINAOALKYL)CARBAMOYL]-9-OXO-9,10-DIHYDROACRIDINES AS INTERCALATING CYTOTOXIC AGENTS - SYNTHESIS, DNA-BINDING, AND BIOLOGICAL EVALUATION, Journal of medicinal chemistry, 40(23), 1997, pp. 3749-3755
Authors:
KOBERLE B
GRIMALDI KA
SUNTERS A
HARTLEY JA
KELLAND LR
MASTERS JRW
Citation: B. Koberle et al., DNA-REPAIR CAPACITY AND CISPLATIN SENSITIVITY OF HUMAN TESTIS TUMOR-CELLS, International journal of cancer, 70(5), 1997, pp. 551-555
Authors:
MASTERS JRW
KNOW RJ
HARTLEY JA
KELLAND LR
HENDRIKS HR
CONNORS T
Citation: Jrw. Masters et al., KW-2149 2-[Y-L-GLUTAMYLAMINO]ETHYLDITHIOETHYL]MITOMYCIN-C) - A NEW MITOMYCIN-C ANALOG ACTIVATED BY SERUM, Biochemical pharmacology, 53(3), 1997, pp. 279-285
Authors:
UCHEGBU IF
DOUBLE JA
KELLAND LR
TURTON JA
FLORENCE AT
Citation: If. Uchegbu et al., THE ACTIVITY OF DOXORUBICIN NIOSOMES AGAINST AN OVARIAN-CANCER CELL-LINE AND 3 IN-VIVO MOUSE-TUMOR MODELS, Journal of drug targeting., 3(5), 1996, pp. 399-409
Authors:
LEE M
SIMPSON JE
BURNS AJ
KUPCHINSKY S
BROOKS N
HARTLEY JA
KELLAND LR
Citation: M. Lee et al., NOVEL PLATINUM(II) DERIVATIVES OF ANALOGS OF NETROPSIN AND DISTAMYCIN- SYNTHESIS, DNA-BINDING AND CYTOTOXIC PROPERTIES, Medicinal chemistry research, 6(6), 1996, pp. 365-371
Authors:
WALTON MI
GODDARD P
KELLAND LR
THURSTON DE
HARRAP KR
Citation: Mi. Walton et al., PRECLINICAL PHARMACOLOGY AND ANTITUMOR-ACTIVITY OF THE NOVEL SEQUENCESELECTIVE DNA MINOR-GROOVE CROSS-LINKING AGENT DSB-120, Cancer chemotherapy and pharmacology, 38(5), 1996, pp. 431-438